Literature DB >> 2742246

Daily use of smokeless tobacco: systemic effects.

N L Benowitz1, P Jacob, L Yu.   

Abstract

STUDY
OBJECTIVE: To compare exposure to nicotine and related cardiovascular effects as well as urinary mutagenicity (a potential marker of systemic absorption of carcinogenic compounds) during use of oral snuff, chewing tobacco, and cigarettes, as desired.
DESIGN: Crossover sequential treatments, balanced-order experimental study.
SETTING: Clinical research center. PARTICIPANTS: Eight healthy men who regularly smoked cigarettes and had previous experience with the use of both oral snuff and chewing tobacco.
INTERVENTIONS: Four 3- or 4-day blocks during which participants used oral snuff, chewing tobacco, and cigarettes as desired, or abstained from all tobacco. Concentrations of nicotine and cotinine (the primary metabolite of nicotine), cardiovascular effects, and urine sodium, catecholamine and mutagenicity were measured over 24 hours at the end of each treatment block.
MEASUREMENTS AND MAIN RESULTS: Circadian exposure to nicotine and cardiovascular effects, including urinary catecholamine excretion, were similar for all forms of tobacco use. Urine sodium excretion was greater while using smokeless tobacco than while smoking, probably due to absorption of sodium from the smokeless tobacco. Urine mutagenicity was markedly increased while smoking cigarettes and tended to be increased (P less than 0.10) while chewing tobacco but not while using oral snuff.
CONCLUSIONS: Systemic absorption of nicotine, sodium, and carcinogenic chemicals from smokeless tobacco may cause or aggravate human illness in addition to the known adverse effects on the oral cavity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2742246     DOI: 10.7326/0003-4819-111-2-112

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  18 in total

1.  Minor tobacco alkaloids as biomarkers for tobacco use: comparison of users of cigarettes, smokeless tobacco, cigars, and pipes.

Authors:  P Jacob; L Yu; A T Shulgin; N L Benowitz
Journal:  Am J Public Health       Date:  1999-05       Impact factor: 9.308

2.  Snuffing tobacco out of sport.

Authors:  G N Connolly; C T Orleans; A Blum
Journal:  Am J Public Health       Date:  1992-03       Impact factor: 9.308

3.  Smokeless tobacco abstinence effects and nicotine gum dose.

Authors:  D Hatsukami; D Anton; R Keenan; A Callies
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

4.  Situational factors and patterns associated with smokeless tobacco use.

Authors:  D K Hatsukami; D Anton; A Callies; R Keenan
Journal:  J Behav Med       Date:  1991-08

5.  Estimating the risks and benefits of nicotine replacement therapy for smoking cessation in the United States.

Authors:  Benjamin J Apelberg; Georgiana Onicescu; Erika Avila-Tang; Jonathan M Samet
Journal:  Am J Public Health       Date:  2009-12-17       Impact factor: 9.308

Review 6.  Biomarkers of exposure to new and emerging tobacco delivery products.

Authors:  Suzaynn F Schick; Benjamin C Blount; Peyton Jacob; Najat A Saliba; John T Bernert; Ahmad El Hellani; Peter Jatlow; R Steven Pappas; Lanqing Wang; Jonathan Foulds; Arunava Ghosh; Stephen S Hecht; John C Gomez; Jessica R Martin; Clementina Mesaros; Sanjay Srivastava; Gideon St Helen; Robert Tarran; Pawel K Lorkiewicz; Ian A Blair; Heather L Kimmel; Claire M Doerschuk; Neal L Benowitz; Aruni Bhatnagar
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-05-18       Impact factor: 5.464

7.  Nicotine blocks the hyperpolarization-activated current Ih and severely impairs the oscillatory behavior of oriens-lacunosum moleculare interneurons.

Authors:  Marilena Griguoli; Alena Maul; Chuong Nguyen; Alejandro Giorgetti; Paolo Carloni; Enrico Cherubini
Journal:  J Neurosci       Date:  2010-08-11       Impact factor: 6.167

8.  Smokeless tobacco, cardiovascular risk factors, and nicotine and cotinine levels in professional baseball players.

Authors:  D Siegel; N Benowitz; V L Ernster; D G Grady; W W Hauck
Journal:  Am J Public Health       Date:  1992-03       Impact factor: 9.308

9.  Psychological predictors of male smokeless tobacco use initiation and cessation: a 16-year longitudinal study.

Authors:  Leela R Holman; Jonathan B Bricker; Bryan A Comstock
Journal:  Addiction       Date:  2013-04-04       Impact factor: 6.526

10.  Modulation of annexin I and cyclooxygenase-2 in smokeless tobacco-induced inflammation and oral cancer.

Authors:  Jamboor K Vishwanatha; Ryan Swinney; Abhijit G Banerjee
Journal:  Mol Cell Biochem       Date:  2003-06       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.